Prognostic significance of p53 abnormalities in colorectal carcinoma detected by PCR-SSCP and immunohistochemical analysis

Journal of Pathology

Volumn 180, Issue 4, 1996, Pages 364-370

  Leahy, Dermot T ^a   Salman, Reem ^a   Mulcahy, Hugh ^a   Sheahan, Kieran ^a   O'Donoghue, Diarmuid P ^a   Parfrey, Nollaig A ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Antigen retrieval; Colorectal carcinoma; p53 protein; PCR SSCP; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SURVIVAL;

AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030443473     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199612)180:4<364::AID-PATH683>3.0.CO;2-0     Document Type: Article

References (32)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
2. Cunningham J, Lust JA, Schaid DJ, et al. Expression of p53 and 17p allelic loss in colorectal cancer. Cancer Res 1992; 52: 1974-1980.
3. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16.
4. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53.
5. Orita M, Suziki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-879.
6. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature I991; 351: 453-456.
7. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932; 35: 323-332.
8. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350: 427-428.
9. Lohmann D, Putz B, Reich U, Bohm J, Prauer H, Hofler H. Mutational spectrum of the p53 gene in human small-cell lung cancer and relationship to clinicopathological data. Am J Pathol 1993; 142: 907-915.
10. Bassam BJ, Caetano-Anolles G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem 1991; 196: 80-83.
11. Lambkin HA, Mothersill CM, Kelehan P. Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 1994; 172: 13-18.
12. Baas IO, Mulder JWR, Offerhaus JA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994; 172: 5-12.
13. Symonds H, Krall L, Remington L, et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994; 78: 703-711.
14. Carder P, Wyllie AH, Purdie CA, et al. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 1993; 8: 1397-1401.
15. Carder PJ, Cripps KJ, Morris R, et al. Mutation of the p53 gene precedes aneuploid clonal divergence in colorectal carcinoma. Br J Cancer 1995; 71: 215-218.
16. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991; 63: 317-319.
17. Starzynska T, Bromley M, Ghosh A, Stern PL. Prognostic significance of p53 overexpression in gastric and colorectal carcinoma. Br J Cancer 1992; 66: 558-562.
18. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993; 104: 57-64.
19. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer and its prognostic significance. Br J Cancer 1993; 68: 399-402.
20. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S, Hakama M. Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 1994; 70: 293-296.
21. Morrin M, Kelly M, Barrett N, Delaney P. Mutations of Ki-ras and p53 genes in colorectal cancer and their prognostic significance. Gut 1994; 35: 1627-1631.
22. Mulder JWR, Baas IO, Polak MM, Goodman SN, Offerhaus GJA. Evaluation of p53 protein as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 1995; 71: 1257-1262.
23. Hamelin R, Laurent-Puig P, Olschwang S, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994; 106: 42-48.
24. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878.
25. Sarkar FH, Kupsky WJ, Li Y-W, Sreepathi P. Analysis of p53 gene mutations in human gliomas by polymerase chain reaction-based single-strand conformation polymorphism and DNA sequencing. Diagn Mol Pathol 1994; 3: 2-8.
26. Burmer GC, Rabinovitch PS, Loeb LA. Analysis of c-Ki-ras mutations in human colon carcinoma by cell sorting, polymerase chain reaction and DNA sequencing. Cancer Res 1989; 49: 2141-2146.
27. Wynford-Thomas D. p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 1992; 166: 329-330.
28. Allred DC, Clark GM, Elledge R, et al. Association of p53 protein expression with tumour cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 1993; 85: 200-206.
29. Momand J, Zaibetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237-1245.
30. Dunn JM, Hastrich DJ, Newcomb P, Webb JCJ, Maitland NJ, Farndon JR. Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg 1993; 80: 1410-1412.
31. Hall PA, Lane DP. p53 in tumour pathology: can we trust immunohistochemistry? - Revisited! J Pathol 1994; 172: l-4.
32. Dowell SP, Hall PA. The p53 tumour suppressor gene and tumour prognosis: is there a relationship? J Pathol 1995; 177: 221-224.